Radiosynthesis and biodistribution of the 99mTc-trovafloxacin complex as a potential methicillin resistant Staphylococcus aureus infection radiotracer

  • Syed Qaiser Shah
  • Muhammad Rafiullah Khan


In the current investigation radiosynthesis of the 99mTc-trovafloxacin (99mTc-TVN) complex and its biodistribution in male Wistar rats (MWR) artificially infected with live and heat killed methicillin resistant Staphylococcus aureus (MRSA) was studied. Further the complex was evaluated in terms of the radiochemical stability in normal saline, in vitro stability in serum and in vitro binding with MRSA. The complex showed radiochemical purity (RCP) in normal saline with a maximum value of 97.30 ± 0.52% at 30 min after its reconstitution. The RCP value went down to 90.45 ± 0.48% within 4 h. In serum at 37 °C, the complex showed permanence up to 4 h but within 16 h of incubation the production of undesirable side product of 17.25% (free and radio-colloid) was observed. In buffer the labeled TVN showed saturated in vitro binding with live MRSA. The uptake of the complex in the thigh of the MWR infected with live MRSA was almost five fold than those infected with heat killed MRSA. The high RCP values, in vitro stability in serum, saturated in vitro binding with MRSA and promising biodistribution with six fold higher accumulation in the infected organ of the MWR infected with live MRSA established the usefulness of the 99mTc-TVN as a promising MRSA infection radiotracer.


99mTc-trovafloxacin complex Biodistribution MRSA Infection radiotracer 


  1. 1.
    Gallagher H, Ramsay SC, Barnes J, Maggs J, Cassidy N, Ketheesan N (2006) Neutrophil labeling with [99mTc]-technetium stannous colloid is complement receptor 3-mediated and increases the neutrophil priming response to lipopolysaccharide. Nucl Med Biol 33:433CrossRefGoogle Scholar
  2. 2.
    Stumpe KDM, Dazzi H, Schaffner A, Schulthess GK (2000) Infection imaging using whole-body FDG-PET. Eur J Nucl Med 27:822CrossRefGoogle Scholar
  3. 3.
    Chattopadhyay S, Das SS, Chandra S, De K, Mishra M, Sarkar BR, Sinha S, Ganguly S (2010) Synthesis and evaluation of 99mTc-moxifloxacin, a potential infection specific imaging agent. Appl Radiat Isotopes 68:314CrossRefGoogle Scholar
  4. 4.
    Motaleb MA (2007) Preparation of 99mTc-cefoperazone complex, a novel agent for detecting sites of infection. J Radioanal Nucl Chem 272:167CrossRefGoogle Scholar
  5. 5.
    Motaleb MA (2007) Preparation and biodistribution of 99mTc-lomefloxacin and 99mTc-olfloxacin complex. J Radioanal Nucl Chem 272:95CrossRefGoogle Scholar
  6. 6.
    Zhang J, Guo H, Zhang S, Lin Y, Wang X (2008) Synthesis and biodistribution of a novel 99mTcN complex of ciprofloxacin dithiocarbamate as a potential agent for infection imaging. Bioorg Med Chem Lett 18:51Google Scholar
  7. 7.
    Roohi S, Mushtaq A, Jehangir M, Ashfaq MS (2006) Synthesis, quality control and biodistribution of 99mTc-Kanamycin. J Radioanal Nucl Chem 267:561CrossRefGoogle Scholar
  8. 8.
    Oh SJ, Ryu J, Shin JW, Yoon EJ, Ha H, Cheon JH, Lee HK (2002) Synthesis of 99mTc-ciprofloxacin by different methods and its biodistribution. Appl Radiat Isot 57:193CrossRefGoogle Scholar
  9. 9.
    EL-Gany EA, EL-Kolaly MT, Amine AM, EL-Sayed AS, Abdel-Gelil F (2005) Synthesis of 99mTc-pefloxacin: a new targeting agent for infectious foci. J Radioanal Nucl Chem 266:131CrossRefGoogle Scholar
  10. 10.
    Motaleb MA (2009) Preparation, quality control and stability of 99mTc-sparafloxacin complex, a novel agent for detecting sites of infection. J Label Compd Radiopharm 52:415CrossRefGoogle Scholar
  11. 11.
    Xia J, Wang Y, Yu J, Li S, Tang L, Zheng M, Liu X, Li G, Cheng D, Liang S, Yin D (2008) Synthesis, in vitro and in vivo behavior of 188Re(I)-tricarbonyl complexes for the future functionalization of biomolecules. J Radioanal Nucl Chem 275:325CrossRefGoogle Scholar
  12. 12.
    Zhang J, Wang X, Jin C (2007) Synthesis and biodistribution of the 99mTc(CO)3-DEDT complex as a potential new radiopharmaceutical for brain imaging. J Radioanal Nucl Chem 272:91CrossRefGoogle Scholar
  13. 13.
    Djokic DD, Jankovic DL, Stamenkovic LL, Pirmettis I (2004) Chemical and biological evaluation of 99mTc (CO)3 and 99mTc complexes of some IDA derivatives. J Radioanal Nucl Chem 260:471CrossRefGoogle Scholar
  14. 14.
    Xia J, Long S, Yu J, Wang Y, Cao Z (2009) Pyridyl derivatives provide new pathways for labeling protein with fac-[188Re(CO)3(H2O)3]+. J Radioanal Nucl Chem 281:493CrossRefGoogle Scholar
  15. 15.
    Zhang JB, Wang XB, Jin C (2006) Synthesis of 99mTc(CO)3-NOET via [99mTc(OH2)3(CO)3]+ precursor and comparative biological studies with 99mTcN-NOET. J Radioanal Nucl Chem 269:227CrossRefGoogle Scholar
  16. 16.
    Qaiser SS, Khan AU, Khan MR (2010) Synthesis, biodistribution and evaluation of 99mTc-Sitafloxacin kit: a novel infection imaging agent. J Radioanal Nucl Chem 284:189CrossRefGoogle Scholar
  17. 17.
    Shah SQ, Khan AU, Khan MR (2010) Radiosynthesis of 99mTc-nitrifuratonin a novel radiotracer for in vivo imaging of Escherichia coli infection. J Radioanal Nucl Chem 287:417Google Scholar
  18. 18.
    Shah SQ, Khan AU, Khan MR (2010) Radiosynthesis and biodistribution of 99mTc-rifampicin: a novel radiotracer for in vivo infection imaging. Appl Radiat Isot 68:2255CrossRefGoogle Scholar
  19. 19.
    Shah SQ, Khan AU, Khan MR (2011) 99mTc-Novobiocin: a novel radiotracer for infection imaging. Radiochimica Acta 99:55Google Scholar
  20. 20.
    Shah SQ, Khan AU, Khan MR (2010) Radiosynthesis, biodistribution and scintigraphy of the 99mTc-Teicoplanin complex in artificially infected animal models. J Label Compd Radiopharm. Online 4 Nov 2010Google Scholar
  21. 21.
    Shah SQ, Khan AU, Khan MR (2010) Radiosynthesis and biological evaluation of 99mTcN-sitafloxacin dithiocarbamate as potential radiotracer for Staphylococcus aureus infection. J Radioanal Nucl Chem. doi: 10.1007/s10967-010-0833-9
  22. 22.
    Shah SQ, Khan AU, Khan MR (2010) Radiosynthesis and biodistribution of 99mTcN-Garenoxacin dithiocarbamate complex a potential infection imaging agent. J Radioanal Nucl Chem. doi: 10.1007/s10967-010-0871-3
  23. 23.
    Shah SQ, Khan AU, Khan MR (2010) Radiosynthesis and biological evolution of 99mTc(CO)3-sitafloxacin dithiocarbamate complex: a promising Staphylococcus aureus infection radiotracer. J Radioanal Nucl Chem. doi: 10.1007/s10967-010-0880-2
  24. 24.
    Shah SQ, Khan AU, Khan MR (2010) 99mTc(CO)3-Garenoxacin dithiocarbamate synthesis and biological evolution in rats infected with multiresistant Staphylococcus aureus and penicillin-resistant Streptococci. J Radioanal Nucl Chem. doi: 10.1007/s10967-010-0892-y
  25. 25.
    Shah SQ, Khan MR (2010) Radiocomplexation and biological characterization of the 99mTcN-Trovafloxacin dithiocarbamate: a novel methicillin-resistant Staphylococcus aureus infection imaging agent. J Radioanal Nucl Chem. doi: 10.1007/s10967-010-0903-z
  26. 26.
    Shah SQ, Khan MR (2010) Synthesis of the 99mTc(CO)3-Trovafloxacin dithiocarbamate complex and biological characterization in artificially methicillin-resistant Staphylococcus aureus infected rats model. J Radioanal Nucl Chem. doi: 10.1007/s10967-010-0914-9
  27. 27.
    Welling MM, Paulusma-Annema A, Batler HS, Pauwels EKJ, Nibbering PH (2000) Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med 27:292CrossRefGoogle Scholar
  28. 28.
    Boschi A, Duatti A, Uccelli L (2005) Development of technetium-99m and rhenium-188 radiopharmacueticals containing a terminal metal-nitrido multiple bond for diagnosis and therapy. Top Curr Chem 252:85Google Scholar
  29. 29.
    Bandoli G, Dolmella A, Porchia M, Tisato E, Refosco P (2001) Structural overview of technetium compounds (1993–1999). Coord Chem Rev 214:43CrossRefGoogle Scholar
  30. 30.
    Schwochau K (2001) Technetium chemistry and radiopharmaceutical applications. Wiley-VCH, WeinheimGoogle Scholar

Copyright information

© Akadémiai Kiadó, Budapest, Hungary 2011

Authors and Affiliations

  1. 1.Nuclear Medicine Research Laboratory (NMRL)University of PeshawarPeshawarPakistan
  2. 2.Phyotopharmaceutical & Neutraceuticals Research Laboratory (PNRL)University of PeshawarPeshawarPakistan

Personalised recommendations